1,800
Participants
Start Date
January 31, 1997
asparaginase
cyclophosphamide
cytarabine
daunorubicin hydrochloride
dexamethasone
doxorubicin hydrochloride
mercaptopurine
methotrexate
pegaspargase
prednisolone
thioguanine
vincristine sulfate
radiation therapy
Oxford Radcliffe Hospital, Oxford
Lead Sponsor
Medical Research Council
OTHER_GOV